What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
His primary areas of investigation include Prostate cancer, Internal medicine, Cancer, Surgery and Oncology.
E. David Crawford has researched Prostate cancer in several fields, including Prostate, Gynecology and Urology.
His Urology research incorporates themes from Antiandrogen, Degarelix, Prostate Cancer Prevention Trial, Finasteride and Performance status.
E. David Crawford works mostly in the field of Cancer, limiting it down to topics relating to Biopsy and, in certain cases, Nephrology, as a part of the same area of interest.
His research integrates issues of Placebo, Carcinoma and Combination therapy in his study of Surgery.
His Oncology research is multidisciplinary, incorporating elements of Metastasis, Proportional hazards model, Family history and Intraepithelial neoplasia.
His most cited work include:
- Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer (3038 citations)
- Mortality Results from a Randomized Prostate-Cancer Screening Trial (2328 citations)
- Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter (2006 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Prostate cancer, Internal medicine, Oncology, Prostate and Cancer.
The Prostate cancer study combines topics in areas such as Gynecology, Surgery and Urology.
The study of Internal medicine is intertwined with the study of Endocrinology in a number of ways.
His studies deal with areas such as Cancer screening, Androgen deprivation therapy, Androgen, Metastasis and Hormonal therapy as well as Oncology.
His work in Prostate addresses issues such as Biopsy, which are connected to fields such as Prostate biopsy.
His research in Prostate-specific antigen intersects with topics in Rectal examination and Mass screening.
He most often published in these fields:
- Prostate cancer (60.49%)
- Internal medicine (58.03%)
- Oncology (43.77%)
What were the highlights of his more recent work (between 2014-2021)?
- Prostate cancer (60.49%)
- Internal medicine (58.03%)
- Oncology (43.77%)
In recent papers he was focusing on the following fields of study:
E. David Crawford mainly focuses on Prostate cancer, Internal medicine, Oncology, Prostate and Biopsy.
His Prostate cancer research includes elements of Radiology and Urology.
His work deals with themes such as Endocrinology and Gynecology, which intersect with Internal medicine.
His Oncology research includes themes of Disease progression, Castration resistant, Enzalutamide, Androgen receptor and Docetaxel.
His research investigates the connection between Prostate and topics such as Nuclear medicine that intersect with issues in Optical Biopsy.
As a part of the same scientific family, E. David Crawford mostly works in the field of Prostate biopsy, focusing on Surgery and, on occasion, Image-Guided Biopsy.
Between 2014 and 2021, his most popular works were:
- Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer (132 citations)
- Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available Therapies (130 citations)
- Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials (101 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Prostate cancer, Internal medicine, Oncology, Prostate and Prostate-specific antigen are his primary areas of study.
The concepts of his Prostate cancer study are interwoven with issues in Prednisone and Urology.
His work focuses on many connections between Internal medicine and other disciplines, such as Endocrinology, that overlap with his field of interest in Agonist.
He combines subjects such as Clinical trial, Enzalutamide, Androgen receptor and Mass screening with his study of Oncology.
His study in Prostate is interdisciplinary in nature, drawing from both Biopsy, Radiology, Disease and Cohort.
His Cancer research focuses on Rate ratio and how it relates to National Death Index.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
